Your Gut Controls Your Muscle: The Microbiome Muscle Axis You Didn't Know Existed

The gut microbiome has had its moment in the health spotlight. Probiotics are on every shelf. Fermented food trend pieces are everywhere. “Gut health” has become a category of its own. Most of the conversation has focused on digestion, immunity, and mental health.

But here’s what that conversation has largely missed: the microbiome has a direct, mechanistic relationship with skeletal muscle. Not a vague “gut health is good for everything” kind of connection, but a specific, well-characterized biological axis involving short-chain fatty acids, inflammatory cytokines, gut barrier function, and mitochondrial substrate supply. This axis determines, in a very real sense, how much muscle you can build and how quickly you lose it as you age.

This is the gut-muscle axis. And it is one of the most consequential biological relationships that performance and longevity science is only now beginning to take seriously.

"Build your microbiome. Build your muscle. The science says these aren't separate goals."

What the gut–muscle axis actually is

Let’s start with the basics. Your gut hosts approximately 38 trillion microorganisms — bacteria, archaea, fungi, and viruses — that collectively weigh around 1–2 kg and encode roughly 150 times more unique genes than the human genome. They are not passengers. They are active metabolic participants in your physiology, producing compounds that enter your bloodstream and exert effects on organs throughout your body.

The gut–muscle axis refers to the bidirectional communication network between this microbial ecosystem and skeletal muscle. Gut bacteria produce metabolites — primarily short-chain fatty acids (SCFAs) — that travel via the portal circulation to influence muscle metabolism, protein synthesis, and inflammatory status. At the same time, skeletal muscle activity — and the substrate availability it creates — shapes which bacterial species thrive in the gut.

Honestly, the fact that this connection is still underappreciated in mainstream performance nutrition is strange. The evidence has been building for over a decade. Ticinesi et al. (2021), in Microorganisms, published a comprehensive review establishing the biological plausibility and epidemiological evidence for this axis, documenting the mechanisms through which the microbiome influences muscle function, muscle mass, and aging.

"Higher gut microbiota diversity is directly linked to greater muscle strength — even after adjusting for age and training level."

How your gut fuels muscle health: the SCFA mechanism

The primary molecular language of the gut–muscle axis is short-chain fatty acids. Produced when beneficial bacteria ferment dietary fibre in the colon, SCFAs primarily butyrate, propionate, and acetate are far more than fermentation byproducts. They're signalling molecules with system-wide biological effects.

Gut barrier protection

Butyrate is the primary fuel source for colonocytes (gut lining cells) and is essential for maintaining tight junction integrity. It prevents the translocation of lipopolysaccharide (LPS) — a bacterial endotoxin — into the bloodstream. LPS translocation, or "leaky gut," triggers systemic inflammation that directly suppresses muscle protein synthesis.

Inflammation reduction

By keeping LPS in the gut, healthy SCFA production prevents the chronic elevation of TNF-alpha, IL-6, and IL-1β that characterises the inflammatory environment of sarcopenia. These cytokines activate muscle protein degradation pathways and suppress IGF-1 signalling — the primary anabolic driver of muscle growth.

Mitochondrial fuel supply

Butyrate isn't just a gut metabolite. It enters the circulation, crosses into muscle cells, and serves as a direct substrate for beta-oxidation — the same metabolic pathway that breaks down fatty acids for ATP. Butyrate essentially acts as extra mitochondrial fuel, supporting the energy demands of both contractile activity and protein synthesis.

mTOR and protein synthesis

SCFAs activate AMPK and influence IGF-1/mTOR signalling pathways that govern muscle protein synthesis. Research in Nature Communications documented that endotoxemia reduces circulating SCFA levels — demonstrating the inverse relationship between barrier dysfunction and the metabolites that support muscle anabolism.

What happens to your gut as you age — and why it matters for muscle

The aging gut microbiome tells a predictable story. And it is not a good one for muscle health.

Starting in midlife and accelerating significantly after age 60, the microbiome undergoes a characteristic dysbiotic shift: microbial diversity drops substantially, species that produce beneficial SCFAs such as Bifidobacterium, Faecalibacterium prausnitzii, and Akkermansia muciniphila decline, and LPS-producing gram-negative bacteria increase in relative abundance.

As butyrate production falls, the gut barrier weakens. LPS enters the circulation in greater quantities. Systemic inflammatory markers rise — CRP, TNF-alpha, and IL-6. And the anabolic environment of skeletal muscle deteriorates in direct proportion.

What happens to the gut with age — the chain reaction

1

Microbiota diversity drops

Beneficial genera such as Bifidobacterium, Akkermansia, and Faecalibacterium decline. The gut ecosystem becomes less resilient and less metabolically productive.

2

SCFA production falls

Less fibre fermentation means less butyrate, propionate, and acetate — reducing gut barrier fuel, systemic anti-inflammatory signals, and mitochondrial substrate availability in muscle.

3

Harmful bacteria rise

LPS-producing gram-negative species increase. Gut barrier permeability rises. Circulating endotoxin increases chronically.

4

Muscle consequences

Elevated TNF-alpha and IL-6 activate ubiquitin-proteasome-mediated protein degradation. IGF-1 signalling is suppressed. The anabolic environment of muscle deteriorates. Sarcopenia accelerates.

Vallianou et al. (2023), in Nutrients, reviewed the specific mechanisms linking gut microbiota composition to sarcopenia risk, documenting that dysbiosis is not merely correlated with muscle aging it is mechanistically implicated in it through SCFA depletion, barrier dysfunction, and the subsequent inflammatory cascade that drives accelerated protein catabolism.

This reframes sarcopenia in an important way. It is not purely a problem of insufficient protein intake or inadequate resistance-training stimulus, although both matter. It is also a problem of the downstream biological environment that those inputs encounter. If that environment is chronically inflamed as it tends to be when the microbiome has shifted toward dysbiosis the return on every gram of protein and every training session is reduced.

"Poor gut balance is strongly linked to sarcopenia as we age — not as a side effect, but as a contributing mechanism."

The research: what the data actually shows

Look. The gut–muscle axis has gone from hypothesis to well-supported science relatively quickly. Let's cover what the research has actually established.

The evidence pathway

Higher gut microbiota diversity → greater muscle strength, independent of age and training level

Better microbiota

→

More SCFAs

→

Lower inflammation

→

Stronger anabolic environment

Multiple cross-sectional studies in both athletes and aging populations have found consistent associations between microbiome diversity metrics and grip strength, appendicular lean mass, and physical function scores. The relationship holds after controlling for confounders including age, caloric intake, protein intake, and training status.

Germ-free mouse models have provided mechanistic confirmation. Mice without a microbiome consistently show reduced muscle mass, impaired muscle fibre development, and attenuated responses to exercise training compared to conventionally colonised animals — demonstrating causality in a way that observational human studies can't.

The intervention evidence is also emerging. Probiotic supplementation (particularly with Lactobacillus and Bifidobacterium strains) has shown modest but real improvements in muscle function markers in older adults, suggesting that actively restoring microbiome composition can move the needle on muscle health outcomes.

How urolithin A supports the gut–muscle axis: the postbiotic connection

Here's where the gut–muscle story connects directly to MuscalarPro's [M3] formulation — and it's a connection that goes beyond what's immediately obvious.

Urolithin A is typically discussed in the context of mitophagy — and rightly so. Its primary studied mechanism is the activation of PINK1/Parkin-mediated mitochondrial quality control. But urolithin A has a secondary role that's equally important for muscle health: it functions as a postbiotic with direct activity in the gut ecosystem.

UROLITHIN A AS A POSTBIOTIC · THE GUT CONNECTION

How urolithin A supports the microbiome–muscle axis from both ends

• Acts as a postbiotic that nourishes beneficial gut bacteria, particularly Akkermansia muciniphila and other SCFA-producing species — increasing butyrate production downstream.
• Its metabolites are utilised by key commensal species, creating a prebiotic-like effect that boosts the representation of gut-health-supporting organisms.
• Strengthens the gut barrier by supporting tight junction protein expression, reducing LPS translocation and the systemic inflammation that suppresses muscle protein synthesis.
• Reduces intestinal permeability-driven inflammation — lowering TNF-alpha and IL-6 at the source rather than just downstream.
• Improves nutrient absorption capacity, ensuring that dietary protein and other anabolic substrates are more efficiently extracted from the gut.

What this means in practice is that urolithin A is working through two separate but complementary pathways to support muscle health. At the cellular level, it's clearing damaged mitochondria and improving energy production efficiency. At the systemic level, it's improving the gut-derived inflammatory and metabolic environment that muscle cells operate in.

That's a genuinely unusual combination. Most compounds work through one mechanism. Urolithin A's evidence base spans both mitochondrial biology and gut ecology — and the two effects are additive in their impact on the conditions that determine muscle protein synthesis.

The benefits stack: urolithin A's dual impact

Direct mitophagy boost

Urolithin A activates PINK1/Parkin-mediated mitophagy, clearing damaged mitochondria and improving cellular energy efficiency in muscle fibres directly.

Indirect anti-inflammatory effect via gut

Better gut microbiota → lower LPS → reduced TNF-alpha and IL-6 → less muscle protein degradation → preserved anabolic signalling.

Overall impact: double-anabolic environment

Creates a stronger, more receptive anabolic environment for muscle growth and maintenance — at both the cellular energy level and the systemic inflammatory level simultaneously.

THE CIRCULAR BENEFIT

Urolithin A

→

Better microbiota

→

More SCFAs

→

Lower inflammation

→

Better muscle protein synthesis

Decode Peak Performance [M3]

★★★★★ · Urolithin A 500mg · Spermidine 3mg · S-allyl cysteine 0.5mg

Mitophagy activation to reduce ROS — targeting the root of the fibrotic cascade.

Patented · Clinically Proven.

Learn more

How to strengthen the gut–muscle axis

The practical protocol for optimising the gut–muscle axis combines lifestyle inputs that directly improve microbiome composition with targeted nutritional support.

Resistance training → boosts SCFA-producing bacteria

Exercise, particularly resistance training, increases the relative abundance of butyrate-producing species including Faecalibacterium prausnitzii. The gut–muscle axis is bidirectional — training your muscle is simultaneously training your gut. This is the most accessible gut-health intervention available, and it doesn't require any dietary changes to implement.

High-fibre diet → fuels healthy fermentation

Dietary fibre is the substrate that SCFA-producing bacteria ferment. Without adequate fibre, the beneficial species simply can't produce meaningful amounts of butyrate, regardless of how many probiotics you take. Target a diverse range of fibre sources — vegetables, legumes, whole grains, resistant starch — not just one fibre supplement.

Adequate protein → leucine supports microbiota and muscle

Leucine — the branched-chain amino acid that triggers muscle protein synthesis — also appears to support beneficial gut bacteria directly. Adequate protein intake serves both anabolic and microbiotic goals simultaneously. The quality of protein matters: leucine-rich sources such as whey, eggs, and meat are most relevant here.

Urolithin A → postbiotic support for key beneficial species

As documented above, urolithin A's metabolites preferentially nourish Akkermansia muciniphila and SCFA-producing species — providing a targeted postbiotic effect that's particularly valuable for adults with aging-related dysbiosis where the beneficial species have already declined.

Optional: fermented foods + targeted probiotic strains

Fermented foods such as yogurt, kefir, kimchi, and sauerkraut provide live cultures that can directly supplement declining populations of beneficial bacteria. Specific strains with performance-relevant evidence — Akkermansia muciniphila and Faecalibacterium prausnitzii — are emerging targets for targeted probiotic supplementation, though strain availability for human supplementation is still developing.

 

What this means for your health

For energy: Butyrate, produced by a healthy gut microbiome, enters muscle cells and serves as direct mitochondrial fuel. A gut that produces substantial butyrate means muscle mitochondria have more substrate available — which translates to better sustained energy output, particularly during moderate-intensity aerobic effort, where fat oxidation dominates.

For aging: The dysbiotic shift that accompanies aging is now understood to be a contributing driver of sarcopenia not just a correlate of it. Addressing microbiome health proactively is, therefore, an anti-sarcopenic strategy. It does not replace resistance training or adequate protein, but it creates the systemic environment in which those inputs can work more effectively.

For metabolic health: LPS-driven inflammation impairs insulin signaling in muscle tissue, directly reducing glucose disposal capacity and contributing to insulin resistance. A healthy gut barrier that keeps LPS contained helps maintain the insulin sensitivity that allows muscle to act as an effective metabolic buffer for glucose.

For cellular resilience: The combination of urolithin A’s mitophagy activation cleaning the mitochondrial pool and its gut-supportive postbiotic activity  reducing the inflammatory burden on muscle cells creates what Image 4 in the M3 series accurately describes as a “double-anabolic environment.”

Better mitochondria. Lower inflammation. More efficient nutrient delivery from a healthier gut. All of it stacks.

KEY TAKEAWAYS

• The gut microbiome communicates with skeletal muscle via the gut–muscle axis — primarily through short-chain fatty acids (SCFAs), gut barrier integrity, and systemic inflammatory regulation.
• Butyrate, produced by beneficial gut bacteria from dietary fibre, serves as mitochondrial fuel in muscle cells, reduces LPS-driven systemic inflammation, and supports the anabolic environment for protein synthesis.
• Higher microbiome diversity is independently associated with greater muscle strength — even after controlling for age, diet, and training status.
• Aging-related dysbiosis — falling diversity, declining SCFA producers, rising LPS bacteria contributes mechanistically to sarcopenia by creating a chronically inflammatory, catabolic muscle environment.
• Urolithin A functions as both a mitophagy activator and a postbiotic nourishing Akkermansia and SCFA-producing species, strengthening the gut barrier, and reducing LPS-driven inflammation that suppresses muscle protein synthesis.
• The gut–muscle axis is bidirectional: resistance training improves microbiome composition, creating a reinforcing positive loop between exercise, gut health, and muscle quality.

Frequently asked questions

What is the gut–muscle axis?

The gut–muscle axis is the bidirectional biological communication network between the gut microbiome and skeletal muscle. Gut bacteria produce short-chain fatty acids (SCFAs) and regulate gut barrier integrity in ways that directly influence muscle metabolism, protein synthesis, and inflammation. In the opposite direction, physical activity, particularly resistance training, shapes microbiome composition — increasing the abundance of beneficial, SCFA-producing species. It's a two-way street, and optimising both sides compounds the benefits.

How does gut bacteria affect muscle growth?

Through several mechanisms. First, beneficial bacteria produce butyrate — a short-chain fatty acid that serves as mitochondrial fuel in muscle cells and supports the energy demands of protein synthesis. Second, butyrate maintains gut barrier integrity, preventing lipopolysaccharide (LPS) from entering the bloodstream. LPS drives the elevation of TNF-alpha and IL-6 that activates muscle protein degradation and suppresses IGF-1/mTOR anabolic signalling. Third, SCFA signalling directly influences insulin sensitivity and nutrient uptake efficiency in muscle tissue.

Is gut health really linked to sarcopenia?

Yes — and the evidence is increasingly mechanistic rather than merely correlational. Aging-related dysbiosis, including microbiome diversity decline, falling SCFA production, and rising LPS-producing bacteria, creates a chronically inflammatory systemic environment that activates muscle protein catabolism and suppresses anabolic signalling. Population studies consistently show that lower microbiome diversity is associated with lower muscle mass and strength in older adults.

What is urolithin A's role in gut health?

Beyond its primary studied function as a mitophagy activator, urolithin A acts as a postbiotic in the gut — its metabolites nourish beneficial bacteria, particularly Akkermansia muciniphila and SCFA-producing species. This preferential nourishment increases butyrate production, strengthens the gut barrier, and reduces LPS translocation. The practical effect is that urolithin A works simultaneously on mitochondrial quality control and on the gut-derived inflammatory and metabolic environment that muscle cells operate in.

Does exercise improve gut microbiome health?

Yes — and this is one of the most compelling aspects of the gut–muscle axis. Exercise, particularly aerobic activity and resistance training, increases the relative abundance of butyrate-producing species including Faecalibacterium prausnitzii, Roseburia hominis, and Akkermansia muciniphila. It also increases overall microbiome diversity. This creates a reinforcing positive loop: training benefits muscle directly while simultaneously improving the microbial environment that further supports muscle anabolism and recovery.

What foods support the gut–muscle axis best?

The evidence points to a few key dietary inputs. High-fibre foods such as vegetables, legumes, whole grains, and resistant starch provide the substrate that SCFA-producing bacteria ferment into butyrate. Fermented foods such as yogurt, kefir, kimchi, and sauerkraut contribute live cultures that supplement beneficial populations. Adequate leucine-rich protein such as whey, eggs, and fish supports both muscle protein synthesis and microbiome composition. Polyphenol-rich foods such as pomegranate, berries, and walnuts provide the precursors from which urolithin A is produced — though gut microbiome variability means direct supplementation is often more reliable than dietary sources.

Closing remarks

There's something genuinely satisfying about an axis like this one. The gut and muscle seem like they shouldn't have much to do with each other. One's a digestive organ. The other's a metabolic powerhouse. And yet when you follow the biology the SCFAs, the LPS, the tight junctions, the inflammatory cytokines, the butyrate slipping into mitochondria the connection is not just real but remarkably consequential.

The practical message isn't complicated. You can't optimise muscle by focusing on muscle alone. The systemic environment that muscle operates in shaped in no small part by the trillion-organism ecosystem in your gut determines how efficiently every training session converts to adaptation, how well every gram of protein converts to synthesis, and how long you hold onto muscle function as you age.

Build your microbiome. Build your muscle. The two aren't separate goals. They never were.

AUTHORS

AS

WRITTEN BY

Dr Ateeb Shaikh

HealthTech and Longevity Digital Twin OS

HP

REVIEWED BY

Dr Harsh Patil

Science-Communication Manager

References

1

Ticinesi, A., et al. (2021). The gut microbiota and muscle: a non-exhaustive review. Microorganisms, 9(3), 466. PubMed

2

Mach, N., & Fuster-Botella, D. (2017). Endurance exercise and gut microbiota: a review. Journal of Sport and Health Science, 6(2), 179–197. PubMed

3

Vallianou, N. G., et al. (2023). The role of the gut microbiota in sarcopenia. Nutrients, 12(5), 1257. PubMed

4

Andreux, P. A., et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism, 1(6), 595–603. PubMed

5

Singh, A., et al. (2022). Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability. European Journal of Clinical Nutrition, 76(2), 297–308. PubMed

6

Sonnenburg, J. L., & Bäckhed, F. (2016). Diet–microbiota interactions as moderators of human metabolism. Nature, 535(7610), 56–64. PubMed